Canon announced the new imagePROGRAF TC-21, successor to the imagePROGRAF TC-20 compact desktop large format printer. As a ...

Nerandomilast significantly slowed lung function decline in patients with IPF, with the 18 mg dose showing a 68.8 mL FVC decline reduction compared with placebo. The trial included 1177 patients ...

Boehringer Ingelheim announced today detailed findings from the Phase III FIBRONEER™-IPF and FIBRONEER™-ILD trials. These studies evaluated nerandomilast, an investigational oral, preferential ...

Boehringer revealed the study, which tested the PDE4B inhibitor in idiopathic pulmonary fibrosis (IPF), met its primary endpoint in September. The update ended the long wait for a molecule capable ...

“After a decade of failed phase 3 trials, we have now a positive trial, which is really important to the treatment of people with IPF.” In the multicenter, double-blind, randomized, placebo ...

Its pipeline is currently headed by VP01 (also known as C21), billed as a first-in-class oral angiotensin II type 2 receptor (AT2R) agonist, which is in phase 2 development for IPF and phase 3 for ...

Idiopathic pulmonary fibrosis (IPF) is a fatal disease that's all the more difficult for patients because of a lack of awareness and investment in supporting people with the condition. In the week ...

It’s more expensive than the Canon EOS 2000D, but our review found that it offers fantastic value for beginners. Its handling is superb, battery life strong and image quality excellent.

Idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) are chronic, progressive interstitial lung diseases characterized by irreversible lung damage and high mortality.